The drug safety sector faces strict regulations that provide safe and effective medicines to patients. Yet with so many restraints the flexibility of pharmacovigilance can be limited. Does this make us innovation adverse? Are we missing new methods and solutions to some of those age of challenges of the industry? Where is real innovation happening today and can it help improve the way drug safety is planned, measured, reported or managed?
We asked some of our speakers from the World Drug Safety Congress Europe to think about this idea. We asked about their biggest challenges in the industry and the potential of alternative solutions to this as well as focus on potential innovative technologies. Can we make processes better, faster or more efficient?
Read what a sample of industry experts think in this free eBook.
Alan Hochberg, Roche
Ulrich Vogel, Boehringer Ingelheim
Abhay Chimankar, Cipla Ltd
Sue Rees, Amgen
The World Drug Safety Congress takes place next week, 11-12 September in London. There's still time to book you place. Visit the website for further information.